The Korean Journal of Medicine

  • 제79권4호
  • /
  • Pages.381-386
  • /
  • 2010
  • /
  • 1738-9364(pISSN)
  • /
  • 2289-0769(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지

정상인과 anti-HCV 양성자에서 인슐린 저항성의 유병률 비교

Comparison of the prevalence of insulin resistance between the HCV Antibody positive and non-infected examinee

  • 장재호 (성균관대학교 의과대학 강북삼성병원 소화기내과) ;
  • 김홍주 (성균관대학교 의과대학 강북삼성병원 소화기내과) ;
  • 박정호 (성균관대학교 의과대학 강북삼성병원 소화기내과) ;
  • 박동일 (성균관대학교 의과대학 강북삼성병원 소화기내과) ;
  • 조용균 (성균관대학교 의과대학 강북삼성병원 소화기내과) ;
  • 손정일 (성균관대학교 의과대학 강북삼성병원 소화기내과) ;
  • 전우규 (성균관대학교 의과대학 강북삼성병원 소화기내과) ;
  • 김병익 (성균관대학교 의과대학 강북삼성병원 소화기내과)
  • Jang, Jae-Ho (Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Kim, Hong-Joo (Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Park, Jung-Ho (Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Park, Dong-Il (Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Cho, Yong-Kyun (Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Sohn, Chong-Il (Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Jeon, Woo-Kyu (Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Kim, Byung-Ik (Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
  • 투고 : 2010.03.17
  • 심사 : 2010.08.16
  • 발행 : 2010.10.01
⟨ 이전 논문 다음 논문 ⟩

초록

목적: 만성 C형 간염 항체 보유자들은 정상인들이나 만성B형 간염에 비해 인슐린 저항성이 생길 가능성이 더 높다는 보고들이 많다. 만성 C형 간염에서 지방간이 50% 이상 발생하는데 이는 인슐린 저항성과 관계되어 있다. 그러나 한국에서 만성 C형 간염 보유자에서 인슐린 저항성과 지방간의 유병률에 대한 역학조사가 없었다. 방법: 2005년 1월부터 2006년 12월까지 본원에서 건강검진을 시행받은 수진자를 대상으로 하였으며, 정상 공복 혈당을 보이고 당뇨의 과거력이 없는 anti-HCV 양성자 90명과 나이, 성별을 맞춘 정상대조군 271명을 서로 비교하였다. 결과: Anti-HCV 양성자와 정상대조군 사이에 체질량 지수와 공복 혈당은 유의한 차이가 없었으나 공복 인슐린 농도가 anti-HCV 양성자에서 유의하게 높았다($9.11{\pm}2.94$ vs. $8.43{\pm}2.70$, p=0.04). 비록 HOMA-IR 값은 anti-HCV 양성자 음성자군 사이에 의미있는 차이는 없었지만($2.035{\pm}0.69$ vs. $1.899{\pm}0.64$, p=0.088), HOMA-IR 값이 2.7 이상으로 인슐린 저항성이 있다고 판단되는 환자의 비율은 anti-HCV 양성자군에서 음성자군에 비해 유의하게 높았다(18.9% vs. 10.3%, p=0.042). 지방간은 복부초음파로 진단하였으며 anti-HCV 양성자보다 정상대조군에서 그 유병률이 의미있게 높았다(20.3% vs. 11.1%, p=0.028). Anti-HCV 양성자에서 다른 변수의 보정 후 지방간 발생에 대한 위험도는 0.294 (95% 신뢰구간 0.099-0.875, p=0.011)이다. 결론: Anti-HCV 양성자군에서 공복 고인슐린혈증을 보였으며 HOMA-IR의 값도 증가하는 경향을 보였으나 지방간 발생은 정상대조군에서 더 많았다.

Background/Aims: Considerable evidence indicates that patients with chronic hepatitis C virus (HCV) infection have a greater risk of developing insulin resistance (IR) compared with non-infected individuals or patients with hepatitis B virus (HBV) infection. Few reports have examined the prevalence of IR and hepatic steatosis in patients with chronic HCV infection in Korea. Methods: Ninety subjects positive for HCV antibody who had normal fasting blood glucose levels and no history of diabetes mellitus were compared with 271 HCV non-infected, age- and sex-matched, healthy examinees between January 2005 and December 2006. Results: No significant differences in the body mass index (BMI) and fasting blood glucose level were found between the anti-HCV-antibody-positive and non-infected groups. The serum fasting insulin level was significantly higher in the HCV-antibody-positive group than in the non-infected group ($9.11{\pm}2.94$ vs. $8.43{\pm}2.70\;{\mu}U$/mL (mean${\pm}$SD), p=0.04). Although the homeostasis model assessment of insulin resistance (HOMA-IR) was not significantly different between the two groups ($2.035{\pm}0.69$ vs. $1.899{\pm}0.64$, p=0.088), the prevalence of insulin resistance (HOMA-IR ${\geq}$2.7) was significantly higher in the anti-HCV positive group (18.9% vs. 10.3%, p=0.042). Hepatic steatosis identified by transabdominal ultrasonography was significantly more frequent in the non-infected group (20.3% vs. 11.1%, p=0.028). Conclusions: The anti-HCV positive subjects had significant hyperinsulinemia and a higher prevalence of insulin resistance than the non-infected group, whereas hepatic steatosis was more frequent in the non-infected group.

키워드

참고문헌

  1. Mehta SH, Strathdee SA, Thomas DL. Association between hepatitis C virus infection and diabetes mellitus. Epidemiol Rev 23:302-312, 2001 https://doi.org/10.1093/oxfordjournals.epirev.a000808
  2. Lecube A, Hernandez C, Genesca J, Simo R. Glucose abnormalities in patients with hepatitis C virus infection. Diabetes Care 29:1140-1149, 2006 https://doi.org/10.2337/dc05-1995
  3. Simo R, Hernandez C, Genesca J, Jardi R, Mesa J. High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 19:998-1000, 1996 https://doi.org/10.2337/diacare.19.9.998
  4. Lecube A, Hernandez C, Genesca J, Esteban JI, Jardi R, Simo R. High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury. Diabetes Care 27:1171-1175, 2004 https://doi.org/10.2337/diacare.27.5.1171
  5. Wang CS, Wang ST, Yao WJ, Chang TT, Chou P. Community-based study of hepatitis C virus infection and type 2 diabetes: an association affected by age and hepatitis severity status. Am J Epidemiol 158:1154-1160, 2003 https://doi.org/10.1093/aje/kwg259
  6. Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, Guo L, Jacob S, Regenstein FG, Zimmerman R, Everhart JE, Wasserfall C, Maclaren NK, Perrillo RP. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 29:328-333, 1999 https://doi.org/10.1002/hep.510290235
  7. Svegliati-Baroni G, Ridolfi F, Di Sario A, Casini A, Marucci L, Gaggiotti G, Orlandoni P, Macarri G, Perego L, Benedetti A, Folli F. Insulin and insulin like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. Hepatology 29:1743-1751, 1999 https://doi.org/10.1002/hep.510290632
  8. Aytug S, Reich D, Sapiro LE, Bernstein D, Begum N. Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology 38:1384-1392, 2003 https://doi.org/10.1016/j.hep.2003.09.012
  9. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, Cristanini G, Tiribelli C. Prevalence of and risk factors for hepatic steatosis in northern Italy. Ann Intern Med 132:112-117, 2000
  10. Asselah T, Rubbia-Brandt L, Marcellin P, Negro F. Steastosis in chronic hepatitis C: why does it really matter? Gut 55:123-130, 2006 https://doi.org/10.1136/gut.2005.069757
  11. Hofer H, Bankl HC, Wrba F, Steindl-Munda P, Peck-Radosavljevic M, Osterreicher C, Mueller C, Gangl A, Ferenci P. Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a. Am J Gastroenterol 97:2880-2885, 2002 https://doi.org/10.1111/j.1572-0241.2002.07056.x
  12. Bugianesi E, Pagotto U, Manini R, Vanni E, Gastaldelli A, de lasio R, Gentilcore E, Natale S, Cassader M, Rizzetto M, Pasquali R, Marchesini G. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab 90:3498-3504, 2005 https://doi.org/10.1210/jc.2004-2240
  13. Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J 292:13-15, 1986 https://doi.org/10.1136/bmj.292.6512.13
  14. Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 3:47-52, 2006
  15. Kwon JH, Bae SH. Current status and clinical course of hepatitis C virus in Korea. Korean J Gastroenterol 51:360-367, 2008
  16. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 133:592-599, 2000 https://doi.org/10.7326/0003-4819-133-8-200010170-00009
  17. Rodger AJ, Roberts S, Lanigan A, Bowden S, Brown T, Crofts N. Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975. Hepatol 32:582-587, 2000 https://doi.org/10.1053/jhep.2000.9714
  18. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha and obesity-induced insulin resistance. Science 271:665-668, 1996 https://doi.org/10.1126/science.271.5249.665
  19. Hwang SJ, Luo JC, Chu CW, Lai CR, Lu CL, Tsay SH, Wu JC, Chang FY, Lee SD. Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation. J Gastroenterol Hepatol 16:190-195, 2001 https://doi.org/10.1046/j.1440-1746.2001.02407.x
  20. Monto A, Alonzo J, Watson JJ, Grunfeld C, Wright TL. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol. Hepatol 36:729-736, 2002 https://doi.org/10.1053/jhep.2002.35064
  21. Lecube A, Hernandez C, Genesca J, Simo R. Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: a case-control study. Diabetes Care 29: 1096-1101, 2006 https://doi.org/10.2337/dc05-2509
  22. Greenberg AS, McDaniel ML. Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest 32(Suppl 3):S24-S34, 2002
  23. Sougleri M, Labropoulou-Karatza C, Paraskevopoulou P, Fragopanagou H, Alexandrides T. Chronic hepatitis C virus infection without cirrhosis induces insulin resistance in patients with $\beta$-thalassaemia major. Eur J Gastroenterol Hepatol 13:1195-1199, 2001 https://doi.org/10.1097/00042737-200110000-00012
  24. Honeyman MC, Stone NL, Harrison LC. T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA2: potential for mimicry with rotavirus and other envirommental agents. Mol Med 4:231-239, 1998
  25. Masini M, Campani D, Boggi U, Menicagli M, Funel N, Pollera M, Lupi R, Del Guerra S, Bugliani M, Torri S, Del Prato S, Mosca F, Filipponi F, Marchetti P. Hepatitis C virus infection and human pancreatic $\beta$-cell dysfunction. Diabetes Care 28:940-941, 2005 https://doi.org/10.2337/diacare.28.4.940
  26. Falcon V, Acost-Rivero N, Chinea G, Gavilondo J, de la Rosa MC, Menendez I, Duenas-Carrera S, Vina A, Garcia W, Gra B, Noa M, Reytor E, Barcelo MT, Alvarez F, Morales-Grillo J. Ultrastructural evidences of HCV infection in hepatocytes of chronically HCV-infected patients. Biochem Biophys Res Commun 305:1085-1090, 2003 https://doi.org/10.1016/S0006-291X(03)00884-2